BREAKING
SiTime Corporation Jumps 5.2% in Broad Rally 1 day ago Guidewire Software Drops 5.9% Amid Sector-Wide Selling 1 day ago Korn Ferry Drops 5.5% in Broad Selloff 1 day ago Commvault Systems (CVLT) Jumps 9.8% to $88.47 1 day ago Nexstar Media Group Stock Jumps 5% Amid Sector-Wide Rally 1 day ago TransMedics Group Shares Jump 5.0% 1 day ago Rambus Inc. Jumps 6.3% 1 day ago Clear Secure, Inc. Drops 6.1% in Broad Selloff 1 day ago DigitalOcean Holdings, Inc. Drops 7.2% in Broad Selloff 2 days ago CleanSpark, Inc. (CLSK) Jumps 5.2% to $10.39 2 days ago SiTime Corporation Jumps 5.2% in Broad Rally 1 day ago Guidewire Software Drops 5.9% Amid Sector-Wide Selling 1 day ago Korn Ferry Drops 5.5% in Broad Selloff 1 day ago Commvault Systems (CVLT) Jumps 9.8% to $88.47 1 day ago Nexstar Media Group Stock Jumps 5% Amid Sector-Wide Rally 1 day ago TransMedics Group Shares Jump 5.0% 1 day ago Rambus Inc. Jumps 6.3% 1 day ago Clear Secure, Inc. Drops 6.1% in Broad Selloff 1 day ago DigitalOcean Holdings, Inc. Drops 7.2% in Broad Selloff 2 days ago CleanSpark, Inc. (CLSK) Jumps 5.2% to $10.39 2 days ago
ADVERTISEMENT
AlphaGraphs

PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2023 financial results

Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a net loss of $2.3 billion, or $0.42 per share, compared to net income of $8.6 billion, or $1.51 per share, last year. Adjusted loss per share was $0.17. Both revenues and earnings surpassed […]

October 31, 2023 1 min read

Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a net loss of $2.3 billion, or $0.42 per share, compared to net income of $8.6 billion, or $1.51 per share, last year. Adjusted loss per share was $0.17. Both revenues and earnings surpassed […]

Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today.

Revenues declined 42% year-over-year to $13.2 billion.

The company reported a net loss of $2.3 billion, or $0.42 per share, compared to net income of $8.6 billion, or $1.51 per share, last year. Adjusted loss per share was $0.17.

Both revenues and earnings surpassed projections but the stock stayed in red during premarket hours on Tuesday.   

For the full year of 2023, Pfizer expects revenue of $58-61 billion and adjusted EPS of $1.45-1.65.

Prior performance

ADVERTISEMENT